for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Processa Pharmaceuticals Inc

PCSA.OQ

Latest Trade

6.90USD

Change

-0.24(-3.36%)

Volume

7,457

Today's Range

6.90

 - 

7.20

52 Week Range

3.50

 - 

14.00

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
7.14
Open
7.05
Volume
7,457
3M AVG Volume
1.89
Today's High
7.20
Today's Low
6.90
52 Week High
14.00
52 Week Low
3.50
Shares Out (MIL)
15.52
Market Cap (MIL)
119.83
Forward P/E
--
Dividend (Yield %)
--

Next Event

Processa Pharmaceuticals Inc Annual Shareholders Meeting

Latest Developments

More

Heatwurx Inc announces management change - Form 8k

Heatwurx Inc announces change in management - Form 8k

Heatwurx announces CFO resignation - Form 8-K

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Processa Pharmaceuticals Inc

Processa Pharmaceuticals, Inc., formerly Heatwurx, Inc., is a pharmaceutical company. The Company is focused on the development of drug products that are intended to improve the survival and/or quality of life for patients who have unmet medical need. The Company’s product portfolio includes 499. It is developing 499 for the treatment of Necrobiosis Lipoidica. It is also developing 499 for the treatment of effects related to head and neck cancer.

Industry

Biotechnology & Drugs

Contact Info

7380 Coca Cola Dr Ste 106

HANOVER, MD

21076-1789

United States

+1.443.7763133

Executive Leadership

David Young

Chairman of the Board, Chief Executive Officer, Founder

Wendy Guy

Founder, Chief Administrative Officer

Sian Bigora

Chief Development Officer, Founder

James H. Stanker

Chief Financial Officer

R. Michael Floyd

Chief Operating Officer

Key Stats

2.00 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2020

0.0K

2021(E)

0.0K
EPS (USD)

2020

-2.540

2021(E)

-0.425
Price To Earnings (TTM)
--
Price To Sales (TTM)
--
Price To Book (MRQ)
4.77
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.71
LT Debt To Equity (MRQ)
0.20
Return on Investment (TTM)
-85.58
Return on Equity (TTM)
-79.86

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up